374 related articles for article (PubMed ID: 16357394)
21. Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer.
Guimaraes AR; Tabatabei S; Dahl D; McDougal WS; Weissleder R; Harisinghani MG
Urology; 2008 Apr; 71(4):708-12. PubMed ID: 18295316
[TBL] [Abstract][Full Text] [Related]
22. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.
Reimer P; Jähnke N; Fiebich M; Schima W; Deckers F; Marx C; Holzknecht N; Saini S
Radiology; 2000 Oct; 217(1):152-8. PubMed ID: 11012438
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Harada T; Tanigawa N; Matsuki M; Nohara T; Narabayashi I
Eur J Radiol; 2007 Sep; 63(3):401-7. PubMed ID: 17398053
[TBL] [Abstract][Full Text] [Related]
24. Overview of nanoparticle use in cancer imaging.
Islam T; Harisinghani MG
Cancer Biomark; 2009; 5(2):61-7. PubMed ID: 19414922
[TBL] [Abstract][Full Text] [Related]
25. Prostate cancer evaluated with ferumoxtran-10-enhanced T2*-weighted MR Imaging at 1.5 and 3.0 T: early experience.
Heesakkers RA; Fütterer JJ; Hövels AM; van den Bosch HC; Scheenen TW; Hoogeveen YL; Barentsz JO
Radiology; 2006 May; 239(2):481-7. PubMed ID: 16641354
[TBL] [Abstract][Full Text] [Related]
26. High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results.
Kimura K; Tanigawa N; Matsuki M; Nohara T; Iwamoto M; Sumiyoshi K; Tanaka S; Takahashi Y; Narumi Y
Breast Cancer; 2010 Oct; 17(4):241-6. PubMed ID: 19575282
[TBL] [Abstract][Full Text] [Related]
27. USPIO-enhanced magnetic resonance imaging for nodal staging in patients with head and neck cancer.
Curvo-Semedo L; Diniz M; Miguéis J; Julião MJ; Martins P; Pinto A; Caseiro-Alves F
J Magn Reson Imaging; 2006 Jul; 24(1):123-31. PubMed ID: 16755542
[TBL] [Abstract][Full Text] [Related]
28. USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria.
Lahaye MJ; Engelen SM; Kessels AG; de Bruïne AP; von Meyenfeldt MF; van Engelshoven JM; van de Velde CJ; Beets GL; Beets-Tan RG
Radiology; 2008 Mar; 246(3):804-11. PubMed ID: 18195379
[TBL] [Abstract][Full Text] [Related]
29. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
[TBL] [Abstract][Full Text] [Related]
30. Cervical lymph node metastases: MR imaging of gadofluorine M and monocrystalline iron oxide nanoparticle-47 in a rabbit model of head and neck cancer.
Choi SH; Han MH; Moon WK; Son KR; Won JK; Kim JH; Kwon BJ; Na DG; Weinmann HJ; Chang KH
Radiology; 2006 Dec; 241(3):753-62. PubMed ID: 17032913
[TBL] [Abstract][Full Text] [Related]
31. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement.
Michel SC; Keller TM; Fröhlich JM; Fink D; Caduff R; Seifert B; Marincek B; Kubik-Huch RA
Radiology; 2002 Nov; 225(2):527-36. PubMed ID: 12409591
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver.
Pauleit D; Textor J; Bachmann R; Conrad R; Flacke S; Layer G; Kreft B; Schild H
Radiology; 2002 Jan; 222(1):73-80. PubMed ID: 11756708
[TBL] [Abstract][Full Text] [Related]
33. Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging--initial findings.
Stadnik TW; Everaert H; Makkat S; Sacré R; Lamote J; Bourgain C
Eur Radiol; 2006 Oct; 16(10):2153-60. PubMed ID: 16670863
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria.
Tokuhara T; Tanigawa N; Matsuki M; Nomura E; Mabuchi H; Lee SW; Tatsumi Y; Nishimura H; Yoshinaka R; Kurisu Y; Narabayashi I
Gastric Cancer; 2008; 11(4):194-200. PubMed ID: 19132480
[TBL] [Abstract][Full Text] [Related]
35. Does quantification of USPIO uptake-related signal loss allow differentiation of benign and malignant normal-sized pelvic lymph nodes?
Froehlich JM; Triantafyllou M; Fleischmann A; Vermathen P; Thalmann GN; Thoeny HC
Contrast Media Mol Imaging; 2012; 7(3):346-55. PubMed ID: 22539405
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes.
Koh DM; George C; Temple L; Collins DJ; Toomey P; Raja A; Bett N; Farhat S; Husband JE; Brown G
AJR Am J Roentgenol; 2010 Jun; 194(6):W505-13. PubMed ID: 20489069
[TBL] [Abstract][Full Text] [Related]
37. Re: Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer.
Kroon BK; Horenblas S
J Urol; 2006 Mar; 175(3 Pt 1):1174. PubMed ID: 16469648
[No Abstract] [Full Text] [Related]
38. Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience.
Bellin MF; Roy C; Kinkel K; Thoumas D; Zaim S; Vanel D; Tuchmann C; Richard F; Jacqmin D; Delcourt A; Challier E; Lebret T; Cluzel P
Radiology; 1998 Jun; 207(3):799-808. PubMed ID: 9609907
[TBL] [Abstract][Full Text] [Related]
39. Comparison of dynamic gadolinium-enhanced and ferumoxides-enhanced MRI of the liver on high- and low-field scanners.
Limanond P; Raman SS; Sayre J; Lu DS
J Magn Reson Imaging; 2004 Oct; 20(4):640-7. PubMed ID: 15390231
[TBL] [Abstract][Full Text] [Related]
40. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings--initial observations.
Koh DM; Brown G; Temple L; Raja A; Toomey P; Bett N; Norman AR; Husband JE
Radiology; 2004 Apr; 231(1):91-9. PubMed ID: 14976266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
